Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Ketosis-Prone Type 2 Diabetes Medication: Antidiabetics, Alpha-Glucosidase Inhibitors, Antidiabetics, Amylinomimetics, Antidiabetics, Biguanides, Antidiabetics, Dipeptidyl Peptidase 4 (DPP-4) Inhibitors, Antidiabetics, Glucagon-like Peptide-1 Agonists, Antidiabetics, Glucose-dependent Insulinotropic Polypeptides, Antidiabetics, Insulins, Antidiabetics, Meglitinide Derivatives, Antidiabetics, SGLT2 Inhibitors, Antidiabetics, Sulfonylureas, Antidiabetics, Thiazolidinediones, Antiparkinson Agents, Dopamine Agonists, Bile Acid Sequestrants, Hypoglycemia Antidotes

Gaba R, Mehta P, Balasubramanyam A. Evaluation and management of ketosis-prone diabetes. Expert Rev Endocrinol Metab . 2019 Jan. 14 (1):43-8. [QxMD MEDLINE Link] . Boike S, Mir M, Rauf I, et al. Ketosis-prone diabetes mellitus: a phenotype that hospitalists ne

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

  • Gaba R, Mehta P, Balasubramanyam A. Evaluation and management of ketosis-prone diabetes. Expert Rev Endocrinol Metab . 2019 Jan. 14 (1):43-8. [QxMD MEDLINE Link] .
  • Boike S, Mir M, Rauf I, et al. Ketosis-prone diabetes mellitus: a phenotype that hospitalists need to understand. World J Clin Cases . 2022 Oct 26. 10(30):10867-72. [QxMD MEDLINE Link] . [Full Text] .
  • Patel SG, Hsu JW, Jahoor F, Coraza I, Bain JR, Stevens RD, et al. Pathogenesis of A⁻β⁺ ketosis-prone diabetes. Diabetes . 2013 Mar. 62 (3):912-22. [QxMD MEDLINE Link] . [Full Text] .
  • Balasubramanyam A. Syndromes of ketosis-prone diabetes. Trans Am Clin Climatol Assoc . 2019. 130:145-55. [QxMD MEDLINE Link] . [Full Text] .
  • Umpierrez GE, Smiley D, Kitabchi AE. Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med . Mar 7 2006. 144(5):350-7. [QxMD MEDLINE Link] .
  • Kubota-Mishra E, Huang X, Minard CG, et al. High Prevalence of A(-)β(+) Ketosis-Prone Diabetes in Children with Type 2 Diabetes and Diabetic Ketoacidosis at Diagnosis: Evidence from the Rare and Atypical Diabetes Network (RADIANT). Pediatr Diabetes . 2024. 2024: [QxMD MEDLINE Link] . [Full Text] .
  • Vaibhav A, Mathai M, Gorman S. Atypical diabetes in children: ketosis-prone type 2 diabetes. BMJ Case Rep . 2013 Jan 8. 2013: [QxMD MEDLINE Link] . [Full Text] .
  • Bakjaji S, Lahoti A, Hoffman RP, Mamilly L. The prevalence of autoimmune diseases in antibody negative type 1 diabetes mellitus. J Pediatr Endocrinol Metab . 2026 Apr 24. 39 (4):342-8. [QxMD MEDLINE Link] .
  • Maldonado M, Hampe CS, Gaur LK, et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab . Nov 2003. 88(11):5090-8. [QxMD MEDLINE Link] .
  • Umpierrez GE, Woo W, Hagopian WA, Isaacs SD, Palmer JP, Gaur LK, et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care . 1999 Sep. 22 (9):1517-23. [QxMD MEDLINE Link] .
  • Hampe CS, Nalini R, Maldonado MR, Hall TR, Garza G, Iyer D, et al. Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus. J Clin Endocrinol Metab . 2007 Feb. 92 (2):462-7. [QxMD MEDLINE Link] .
  • Brooks-Worrell BM, Iyer D, Coraza I, Hampe CS, Nalini R, Ozer K, et al. Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes. Diabetes Care . 2013 Dec. 36 (12):4098-103. [QxMD MEDLINE Link] .
  • Sakamoto K, Arnolds DE, Fujii N, Kramer HF, Hirshman MF, Goodyear LJ. Role of Akt2 in contraction-stimulated cell signaling and glucose uptake in skeletal muscle. Am J Physiol Endocrinol Metab . 2006 Nov. 291 (5):E1031-7. [QxMD MEDLINE Link] . [Full Text] .
  • Satomura A, Oikawa Y, Haisa A, et al. Clinical significance of insulin peptide-specific interferon-γ-related immune responses in ketosis-prone type 2 diabetes. J Clin Endocrinol Metab . 2022 Apr 19. 107 (5):e2124-32. [QxMD MEDLINE Link] . [Full Text] .
  • He X, Luo Y, Hao J, et al. Association between serum vitamin D levels and ketosis episodes in hospitalized patients with newly diagnosed ketosis-prone type 2 diabetes. Diabetes Metab Syndr Obes . 2022. 15:3821-9. [QxMD MEDLINE Link] . [Full Text] .
  • Balasubramanyam A, Garza G, Rodriguez L, et al. Accuracy and predictive value of classification schemes for ketosis-prone diabetes. Diabetes Care . Dec 2006. 29(12):2575-9. [QxMD MEDLINE Link] .
  • Vellanki P, Umpierrez GE. Diabetic ketoacidosis: a common debut of diabetes among African Americans with type 2 diabetes. Endocr Pract . 2017 Aug. 23 (8):971-8. [QxMD MEDLINE Link] .
  • Zhang M, Li Y, Cui W, et al. The clinical and metabolic characteristics of young-onset ketosis-prone type 2 diabetes in China. Endocr Pract . 2015 Dec. 21 (12):1364-71. [QxMD MEDLINE Link] .
  • Wang X, Tan H. Male predominance in ketosis-prone diabetes mellitus. Biomed Rep . 2015 Jul. 3 (4):439-442. [QxMD MEDLINE Link] . [Full Text] .
  • Tosur M, Aras S, Golani K, et al. 1329-P: Characterization of Pediatric Ketosis-Prone Diabetes—Findings from the SEARCH for Diabetes in Youth Study. Diabetes . 20 Jun 2025. 74 (Supp_1):1329-P. [Full Text] .
  • [Guideline] Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care . 2024 Aug 1. 47 (8):1257-75. [QxMD MEDLINE Link] . [Full Text] .
  • Wang Y, Lu C, Augusto Monteiro Cardoso Lopes M, et al. A Cross-Sectional Study of Atherosclerosis in Newly Diagnosed Patients with Ketosis-Prone Type 2 Diabetes. Diabetes Metab Syndr Obes . 2022. 15:933-41. [QxMD MEDLINE Link] . [Full Text] .
  • Smolenski S, George NM. Management of ketosis-prone type 2 diabetes mellitus. J Am Assoc Nurse Pract . 2019 Jul. 31 (7):430-6. [QxMD MEDLINE Link] .
  • Mulukutla SN, Tersey SA, Hampe CS, Mirmira RG, Balasubramanyam A. Elevated unmethylated and methylated insulin DNA are unique markers of A+β+ ketosis prone diabetes. J Diabetes Complications . 2018 Feb. 32 (2):193-5. [QxMD MEDLINE Link] . [Full Text] .
  • Ginde AA, Pelletier AJ, Camargo CA Jr. National study of U.S. emergency department visits with diabetic ketoacidosis, 1993-2003. Diabetes Care . Sep 2006. 29(9):2117-9. [QxMD MEDLINE Link] .
  • Bull SV, Douglas IS, Foster M, Albert RK. Mandatory protocol for treating adult patients with diabetic ketoacidosis decreases intensive care unit and hospital lengths of stay: results of a nonrandomized trial. Crit Care Med . Jan 2007. 35(1):41-6. [QxMD MEDLINE Link] .
  • Raubenheimer PJ, Skelton J, Peya B, Dave JA, Levitt NS. Phenotype and predictors of insulin independence in adults presenting with diabetic ketoacidosis: a prospective cohort study. Diabetologia . 2024 Mar. 67 (3):494-505. [QxMD MEDLINE Link] . [Full Text] .
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides

01
Peptide Therapy Guide Editorial Team

Type 2 Diabetes Mellitus Medication: Antidiabetics, Biguanides, Antidiabetics, Glucagon-like Peptide-1 Agonists, Antidiabetics, SGLT2 Inhibitors, Antidiabetics, Dipeptidyl Peptidase 4 (DPP-4) Inhibitors, Antidiabetics, Sulfonylureas, Antidiabetics, Meglitinide Derivatives, Antidiabetics, Alpha-Glucosidase Inhibitors, Antidiabetics, Thiazolidinediones, Aldosterone Antagonists, Selective, Antidiabetics, Amylinomimetics, Bile Acid Sequestrants, Antiparkinson Agents, Dopamine Agonists, Antidiabetics, Rapid-Acting Insulins, Antidiabetics, Short-Acting Insulins, Antidiabetics, Intermediate-Acting Insulins, Antidiabetics, Long-Acting Insulins

Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care . 2003 Jan. 26 Suppl 1:S5-20. [QxMD MEDLINE Link] . Parker ED, Lin J, Mahoney T, et al. Economic Costs of …

Read guide →